A market report lists several Indian companies, including Maruti Suzuki and Aurobindo Pharma, as laggards or movers following a global oil price drop.
2 reports, 2 independent
Updated Jun 15
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A market report lists several Indian companies, including Maruti Suzuki and Aurobindo Pharma, as laggards or movers following a global oil price drop.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Maruti Suzuki
Japanese-Indian automobile manufacturer
-
Aurobindo Pharma
an Indian pharmaceutical company
Related events
- Indian market performance reflects global trends.
- War in West Asia is driving fuel price hikes in India, while Maruti Suzuki maintains its position as a car market leader.
- The generic drug market is seeing significant growth, driven by Indian firms and regional markets, with major players like Aurobindo, J&J, and GSK involved.
- Hyundai Motor India Limited and Maruti Suzuki are major players in the Indian auto market.